Biologic Replacement for Fibrin Clot
6 Assignments
0 Petitions
Accused Products
Abstract
The invention provides methods and devices for repairing a ruptured ligament, meniscus, cartilage, tendon, and bone. Methods and products for delivering nucleic acids to damaged tissue are also disclosed.
-
Citations
121 Claims
-
1-70. -70. (canceled)
-
71. A method for in situ gene transfer comprising:
-
applying a hydrogel containing a non-viral gene transfer vehicle to a tissue site, wherein the tissue is not bone, and promoting cell migration into the hydrogel to accomplish gene transfer into the cell. - View Dependent Claims (72, 75, 76, 79, 85, 86, 88, 89, 90, 91)
-
-
73-74. -74. (canceled)
-
77-78. -78. (canceled)
-
80-84. -84. (canceled)
-
87. (canceled)
-
92-97. -97. (canceled)
-
98. A method for in situ gene transfer comprising:
-
applying a hydrogel containing a viral gene transfer vehicle to a tissue site, wherein the tissue is not a tendon, and promoting cell migration into the hydrogel to accomplish gene transfer in to the cell, wherein the hydrogel forms a scaffold for tissue repair. - View Dependent Claims (99, 101, 102, 104)
-
-
100. (canceled)
-
103. (canceled)
-
105-107. -107. (canceled)
-
108. A method for in situ gene transfer comprising:
-
applying a hydrogel containing a non-nucleic acid based gene transfer vehicle to a tissue site, and promoting cell migration into the hydrogel to accomplish gene transfer into the cell. - View Dependent Claims (109, 111, 112)
-
-
110. (canceled)
-
113-117. -117. (canceled)
-
118. A composition comprising,
a hydrogel containing a gene transfer vehicle, wherein the hydrogel is free of cells and wherein the hydrogel includes soluble type I collagen, a plurality of platelets and a neutralizing agent.
-
121-123. -123. (canceled)
Specification